Profil
Julian Clement Hirst is the founder of Yellowstone Biosciences Ltd.
(founded in 2023) and holds the title of Chief Financial Officer.
He also held former positions as a Non-Executive Director at Oncimmune Ltd., an Independent Non-Executive Director at Oncimmune Holdings Plc (from 2016 to 2020), Finance Director at Immunocore Holdings Plc, and Head of Corporate Finance at Panmure Gordon (UK) Ltd.
(from 2005 to 2006).
Aktive Positionen von Julian Hirst
| Unternehmen | Position | Beginn |
|---|
Ehemalige bekannte Positionen von Julian Hirst
| Unternehmen | Position | Ende |
|---|---|---|
| ONCIMMUNE HOLDINGS PLC | Direktor/Vorstandsmitglied | 04.06.2020 |
Panmure Gordon (UK) Ltd.
 Panmure Gordon (UK) Ltd. Investment Banks/BrokersFinance Panmure Gordon (UK) Ltd. (PGL) is the stockbroking subsidiary of Panmure Gordon & Co. Ltd. in Great Britain. Headquartered in London, the firm was founded in 2003 and provides corporate finance advice, distributes and trades securities and produces investment research to UK small and mid-cap corporates and investment companies. PGL has access to capital markets via a range of equity and equity-linked products such as IPOs, accelerated book buildings, placings, rights issues, and bought deals. The firm's institutional equities department provides UK-focused research, sales and trading services to institutional investors in the UK, US and Europe. | Trading-Equity | 01.01.2006 |
Oncimmune Ltd.
 Oncimmune Ltd. BiotechnologyHealth Technology Oncimmune Ltd. provides clinical testing services for cancer detection. The firm develops early cancer detection tests for lung, breast, colorectal, prostate, stomach, pancreatic and ovarian cancers. The company was founded by John F. R. Robertson in 2003 and is headquartered in Nottingham, the United Kingdom. | Direktor/Vorstandsmitglied | - |
| IMMUNOCORE HOLDINGS PLC | Finanzdirektor/CFO | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ONCIMMUNE HOLDINGS PLC | Health Technology |
| IMMUNOCORE HOLDINGS PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Panmure Gordon (UK) Ltd.
Panmure Gordon (UK) Ltd. Investment Banks/BrokersFinance Panmure Gordon (UK) Ltd. (PGL) is the stockbroking subsidiary of Panmure Gordon & Co. Ltd. in Great Britain. Headquartered in London, the firm was founded in 2003 and provides corporate finance advice, distributes and trades securities and produces investment research to UK small and mid-cap corporates and investment companies. PGL has access to capital markets via a range of equity and equity-linked products such as IPOs, accelerated book buildings, placings, rights issues, and bought deals. The firm's institutional equities department provides UK-focused research, sales and trading services to institutional investors in the UK, US and Europe. | Finance |
Oncimmune Ltd.
Oncimmune Ltd. BiotechnologyHealth Technology Oncimmune Ltd. provides clinical testing services for cancer detection. The firm develops early cancer detection tests for lung, breast, colorectal, prostate, stomach, pancreatic and ovarian cancers. The company was founded by John F. R. Robertson in 2003 and is headquartered in Nottingham, the United Kingdom. | Health Technology |
